GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 80 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $5,647,000 | +65.1% | 649,097 | 0.0% | 0.27% | +36.5% |
| Q1 2016 | $3,421,000 | -32.1% | 649,097 | 0.0% | 0.20% | -38.5% |
| Q4 2015 | $5,037,000 | -11.6% | 649,097 | -10.4% | 0.32% | -33.4% |
| Q3 2015 | $5,699,000 | -38.2% | 724,097 | -28.9% | 0.49% | -22.3% |
| Q2 2015 | $9,222,000 | -52.1% | 1,017,897 | -31.3% | 0.63% | -54.3% |
| Q1 2015 | $19,245,000 | -19.1% | 1,482,662 | -15.2% | 1.37% | -13.1% |
| Q4 2014 | $23,792,000 | +192.1% | 1,748,100 | +92.5% | 1.58% | +106.5% |
| Q3 2014 | $8,146,000 | -33.7% | 908,100 | 0.0% | 0.77% | -4.8% |
| Q2 2014 | $12,287,000 | +36.1% | 908,100 | 0.0% | 0.80% | +13.9% |
| Q1 2014 | $9,027,000 | -28.6% | 908,100 | -4.4% | 0.71% | -36.6% |
| Q4 2013 | $12,644,000 | +9.5% | 950,000 | 0.0% | 1.12% | -7.9% |
| Q3 2013 | $11,542,000 | +17.5% | 950,000 | 0.0% | 1.21% | +19.8% |
| Q2 2013 | $9,823,000 | – | 950,000 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |